Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Name: Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Published: 2008
License: Public Domain

Biogen · 2008

ClinicalTrials.gov · Datasets · License: Public Domain · 2008

Open Source ↗

antibody

chronic lymphocytic leukemia, fludara, cd23, cyclophosphamide, antibody, fludarabine, cll, rituximab, mabthera, biogen idec, lumiliximab, rituxan

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 854576
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.